Chemours Announces Dates for Second Quarter 2024 Earnings Release and Webcast Conference Call

7/11/24 4:15:00 PM ET

Major Chemicals

Industrials

Get the next $CC alert in real time by email

The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its second quarter 2024 financial results after market close on Thursday, August 1, 2024.

The Company expects to hold its conference call to discuss its second quarter 2024 financial results at 8:00 a.m. Eastern Daylight Time on Friday, August 2, 2024. The call is open to the public and can be accessed via the below webcast information.

Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides.

Replay: A webcast replay will be available at investors.chemours.com.

About The Chemours Company

The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our flagship products are sold under prominent brands such as Ti-Pure™, Opteon™, Freon™, Teflon™, Viton™, Nafion™, and Krytox™. The Company has approximately 6,200 employees and 28 manufacturing sites, and serves approximately 2,700 customers in approximately 110 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on X (formerly Twitter) @Chemours or on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240711794637/en/

Get the next $CC alert in real time by email

Recent Analyst Ratings for

$CC

Date	Price Target	Rating	Analyst
7/9/2024	$28.00 → $30.00	Neutral → Buy	UBS
6/7/2024	$25.00	Neutral	Mizuho
4/9/2024	$19.00 → $34.00	Underperform → Outperform	BMO Capital Markets
3/5/2024	$37.00 → $21.00	Buy → Neutral	UBS
2/29/2024	$45.00 → $19.00	Outperform → Underperform	BMO Capital Markets
12/1/2023	$28.00 → $40.00	Sector Perform → Outperform	RBC Capital Mkts
6/22/2023	$41.00 → $37.00	Buy → Neutral	BofA Securities
1/24/2023	$31.00 → $43.00	Neutral → Buy	UBS

More analyst ratings

Chemours Announces Dates for Second Quarter 2024 Earnings Release and Webcast Conference Call

Chat with this insight

Recent Analyst Ratings for $CC

$CC Press Releases

Fastest customizable press release news feed in the world

The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033

The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033

Chemours Announces Fourth Quarter Dividend

$CC Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Chemours Company

SEC Form SC 13G/A filed by Chemours Company (Amendment)

SEC Form SC 13G/A filed by Chemours Company (Amendment)

$CC Financials

Live finance-specific insights

$CC SEC Filings

Chemours Announces Fourth Quarter Dividend

Chemours Announces Dates for Third Quarter 2024 Earnings Release and Webcast Conference Call

Chemours Announces Third Quarter Dividend

Chemours Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

SEC Form 10-Q filed by Chemours Company

Chemours Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$CC Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Chemours upgraded by UBS with a new price target

Mizuho initiated coverage on Chemours with a new price target

Chemours upgraded by BMO Capital Markets with a new price target

$CC Leadership Updates

Live Leadership Updates

Amprius Appoints Transportation Industry Veteran Tony Satterthwaite to Board of Directors

Chemours Names Tony Satterthwaite to Board of Directors

Chemours Appoints Shane Hostetter as Chief Financial Officer

$CC Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Cowan Alister was granted 10,200 shares, increasing direct ownership by 90% to 21,583 units (SEC Form 4)

SVP Corp Communications & CBO Scarborough Alvenia sold $154,771 worth of shares (7,500 units at $20.64), decreasing direct ownership by 31% to 16,645 units (SEC Form 4)

Chief Accounting Officer Will David was granted 20,984 shares (SEC Form 4)

$CC Market Insights

Live Market Insights

Chemours shares are trading higher after UBS upgraded the stock from Neutral to Buy and raised its price target from $28 to $30.

UBS Upgrades Chemours to Buy, Raises Price Target to $30

Reported Earlier, Chemours Company Announced That The Mexican Government Has Lifted Its Prior Water Intake Restrictions, Enabling The Company To Resume Normal Operations At Its Titanium Dioxide (tio2) Manufacturing Facility In Altamira, Mexico.

Recent Analyst Ratings for
$CC

$CC
Press Releases

$CC
Large Ownership Changes

$CC
Financials

$CC
SEC Filings

$CC
Analyst Ratings

$CC
Leadership Updates

$CC
Insider Trading

$CC
Market Insights